Restructuring Reserve
McKesson Restructuring Reserve decreased by 50.0% to $35.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 77.7%, from $157.00M to $35.00M. Over 4 years (FY 2021 to FY 2025), Restructuring Reserve shows a downward trend with a -4.4% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
An increase indicates active cost-cutting or strategic realignment, while a decrease suggests the completion of restructuring phases.
Detailed definition
This represents the estimated liability for costs associated with formal restructuring plans, such as workforce reductio...
Peer comparison
Varies significantly based on the company's current phase of operational transformation.
restructuring_reserveHistorical Data
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $177.00M | $161.00M | $144.00M | $130.00M | $116.00M | $109.00M | $72.00M | $92.00M | $74.00M | $66.00M | $54.00M | $55.00M | $43.00M | $188.00M | $157.00M | $126.00M | $88.00M | $70.00M | $35.00M |
| QoQ Change | — | -9.0% | -10.6% | -9.7% | -10.8% | -6.0% | -33.9% | +27.8% | -19.6% | -10.8% | -18.2% | +1.9% | -21.8% | +337.2% | -16.5% | -19.7% | -30.2% | -20.5% | -50.0% |
| YoY Change | — | — | — | — | -34.5% | -32.3% | -50.0% | -29.2% | -36.2% | -39.4% | -25.0% | -40.2% | -41.9% | +184.8% | +190.7% | +129.1% | +104.7% | -62.8% | -77.7% |
Business Segments
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | Q4 '26 |
|---|---|---|---|---|---|---|---|---|
| Medical-Surgical Solutions | $0.00 | $144.00M | $111.00M | $90.00M | $57.00M | $39.00M | $6.00M | $10.00M |
| Prescription Technology Solutions | $5.00M | $4.00M | $2.00M | $1.00M | $1.00M | $0.00 | $0.00 | $3.00M |
| International | $8.00M | $2.00M | $2.00M | $1.00M | $1.00M | — | — | — |
| U.S. Pharmaceutical | $14.00M | $14.00M | $15.00M | $10.00M | $9.00M | — | — | — |
| Total | $43.00M | $188.00M | $157.00M | $126.00M | $88.00M | $70.00M | $35.00M | — |
International, U.S. Pharmaceutical were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.
Restructuring Reserve at Other Companies
Frequently Asked Questions
- What is McKesson's restructuring reserve?
- McKesson (MCK) reported restructuring reserve of $35.00M in Q4 2025.
- How has McKesson's restructuring reserve changed year-over-year?
- McKesson's restructuring reserve decreased by 77.7% year-over-year, from $157.00M to $35.00M.
- What is the long-term trend for McKesson's restructuring reserve?
- Over 4 years (2021 to 2025), McKesson's restructuring reserve has grown at a -4.4% compound annual growth rate (CAGR), from $151.00M to $126.00M.
- What does restructuring reserve mean?
- Funds set aside to cover the costs of reorganizing or downsizing business operations.